Randomized discontinuation trials: Utility and efficiency
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The randomized discontinuation trial (RDT) is a two-phase trial. In phase I all patients are openly treated with the medication being evaluated. In phase II, those who have responded are randomly assigned to continue the same treatment or switch to placebo. Usually, non-compliers and "adverse reactors" identified in phase I are excluded from phase II. To investigate the value of this design, we reviewed the advantages and limitations of discontinuation studies, and compared the RDT design to the classic randomized clinical trial design in terms of clinical utility and efficiency (sample size). A computer model was used to study the efficiency of the two designs under a broad range of assumptions. The RDT design is particularly useful in studying the effect of long-term, non-curative therapies, especially when the clinically important effect is relatively small, and the use of placebo should be minimized for ethical or feasibility reasons. However, its use is limited if the objective of an investigation is to estimate the magnitude of absolute treatment effects and toxic effects in the source population, or to evaluate a potentially curative treatment. Our results indicate that selecting responders prior to randomization has a very strong effect on the relative efficiency of the trial. Further improvement may be achieved by excluding non-compliers and adverse reactors. Under the assumptions tested in our model, the sample size required in phase II of an RDT was only 20-50% of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,253
Fundamentals of Clinical Trials
Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015) · doi:10.1007/978-3-319-18539-2 · Cited by 2,237
Statistical Methods in Medical Research.
Wickham, C. A. C., Armitage, P., & Berry, G. (1988) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2982765 · Cited by 1,397
(1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240303 · Cited by 677
Patient Compliance in Medical Practice and Clinical Trials
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-7-582_3 · Cited by 464
A CLICKING HIP IN A NEWBORN BABY SHOULD NEVER BE IGNORED
Cunningham, K. T., Beningfield, S., Moulton, A., & Maddock, C. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92180-9 · Cited by 387
Fundamentals of Clinical Trials
Rhoads, G. G. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380080101043 · Cited by 342
Stones in the kidney and ureter.
Hellström, J. (1948) · PubMed · Cited by 323
Long-term Diazepam Therapy and Clinical Outcome
Rickels, K. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03340060045024 · Cited by 276
Long-term Diazepam Therapy and Clinical Outcome
Rickels, K. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.250.6.767 · Cited by 276
Coiffier, B., Gisselbrecht, C., Herbrecht, R., Tilly, H., Bosly, A., & Brousse, N. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.8.1018 · Cited by 254
Sixty Plus Reinfarction Study Research Group (1980) · The Lancet · doi:10.1016/s0140-6736(80)92154-6 · Cited by 254
Dietary Therapy Slows the Return of Hypertension After Stopping Prolonged Medication
Langford, H. G. (1985) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1985.03350290063027 · Cited by 252
Letter: Cardiac arrhythmia induced by phenothiazine.
Df, L., & Marshall, A. J. (1975) · PubMed · Cited by 246
Long-term outcome of antidepressant treatment for bulimia nervosa
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.9.1206 · Cited by 219
Recurrent Vulvovaginal Candidiasis
Sobel, J. D. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152305 · Cited by 217
Cromolyn sodium in the management of systemic mastocytosis
Horan, R. F., Sheffer, A. L., & Austen, K. F. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(90)90067-e · Cited by 164
Dawson, P. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92701-9 · Cited by 146
Sample sizes for medical trials with special reference to long-term therapy
Halperin, M., Rogot, E., Gurian, J. M., & Ederer, F. (1968) · Journal of Chronic Diseases · doi:10.1016/0021-9681(68)90082-9 · Cited by 135
Stellon, A. J., Keating, J. J., Johnson, P. J., McFarlane, I. G., & Williams, R. (1988) · Hepatology · doi:10.1002/hep.1840080414 · Cited by 135
The Scottish first episode schizophrenia study: VII. Two‐year follow‐up
Scottish Schizophrenia Research Group, McCreadie, R. G., Wiles, D., Grant, S., Crockett, G. T., Mahmood, Z., Livingston, M. G., Watt, J. A. G., Greene, J. G., Kershaw, P. W., et al. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb03032.x · Cited by 120
DiBianco, R., Shabetai, R. W., Silverman, B. D., Leier, C. V., & Benotti, J. R. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80044-3 · Cited by 116
The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis
Caldwell, J. R., & Fürst, D. E. (1991) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(91)90051-z · Cited by 115
LONG-TERM INTERFERON THERAPY FOR THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISEASES
Gisslinger, H., Linkesch, W., Fritz, E., Ludwig, H., Chott, A., & Radaszkiewicz, T. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92142-9 · Cited by 105
Liebowitz, M. R., Gorman, J. M., Fyer, A. J., Campeas, R. B., Levin, A. P., Sandberg, D., Hollander, E., Papp, L. A., & Goetz, D. M. (1988) · PubMed · Cited by 102
Effect of Gradual Withdrawal on the Rebound Sleep Disorder after Discontinuation of Triazolam
Greenblatt, D. J., Harmatz, J. S., Zinny, M. A., & Shader, R. I. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709173171202 · Cited by 96
RAPID RECURRENCE OF MANIA FOLLOWING ABRUPT DISCONTINUATION OF LITHIUM
Mander, A. J., & Loudon, J. B. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92947-9 · Cited by 86
A Clinical Trial Design Avoiding Undue Placebo Treatment
AMERY, W., & DONY, J. (1975) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1975.tb05919.x · Cited by 83
Mavissakalian, M., & Perel, J. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.318 · Cited by 82
Robinson, D. S., Sc, L., Bennett, B., Laux, D. E., Devereaux, E., Kayser, A., CORCELLA, J., & ALBRIGHT, D. (1991) · PubMed · Cited by 79
Fabricius, P. G., Weizert, P., Dunzendorfer, U., Hannaford, J. M., & Maurath, C. J. (1990) · The Prostate · doi:10.1002/pros.2990170509 · Cited by 72
FLUNARIZINE IN ALTERNATING HEMIPLEGIA IN CHILDHOOD
Casaer, P., & Azou, M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90794-3 · Cited by 71
RANDOMISED CONTROLLED TRIAL OF AZATHIOPRINE WITHDRAWAL IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
Stellon, A. J., Portmann, B. C., Hegarty, J., & Williams, R. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91329-7 · Cited by 64
Flunarizine in Alternating Hemiplegia in Childhood. An International Study in 12 Children
Casaer, P., Aicardi, J. F., Curatolo, P., Dias, K., Maia, M., Motte, J., Pineda, M., Pouplard, F., Preney-Cramatte, S., Stephenson, J., et al. (1987) · Neuropediatrics · doi:10.1055/s-2008-1052478 · Cited by 64
Knipschild, P. G., Leffers, P., & Feinstein, A. R. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90208-q · Cited by 59
The use of a run‐in to enhance compliance
Lang, J. M. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090115 · Cited by 56
Schork, M. A., & Remington, R. D. (1967) · Journal of Chronic Diseases · doi:10.1016/0021-9681(67)90005-7 · Cited by 53
Lederle, F. A., Pluhar, R. E., Joseph, A. M., & Niewoehner, D. E. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.12.2201 · Cited by 53
The run-in period in clinical trials
Brittain, E., & Wittes, J. T. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90174-z · Cited by 48
Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.12.1622 · Cited by 47
Dietary therapy slows the return of hypertension after stopping prolonged medication
Langford, H. G. (1985) · JAMA · doi:10.1001/jama.253.5.657 · Cited by 46
The effect of withdrawing antihypertensive therapy: a review
FLETCHER, A. E., Franks, P. J., & Bulpitt, C. J. (1988) · Journal of Hypertension · doi:10.1097/00004872-198806000-00001 · Cited by 35
Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
Eklund, K. L., & Forsman, A. (1991) · PubMed · Cited by 32
Ruskin, P. E., & Nyman, G. E. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199104000-00006 · Cited by 31
D-penicillamine withdrawal in rheumatoid arthritis.
Ahern, M. J., Hall, N. D., Case, K., & Maddison, P. (1984) · Annals of the Rheumatic Diseases · doi:10.1136/ard.43.2.213 · Cited by 30
Effects of reduction in drugs or dosage after long-term control of systemic hypertension
Freis, E. D., Thomas, J. R., Fisher, S. G., Hamburger, R. J., Borreson, R. E., Mezey, K. C., Mukherji, B., Neal, W. W., Perry, H. M., & Taguchi, J. T. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90255-5 · Cited by 23
β‐Receptor Blockade and Spinal Anaesthesia. Withdrawal versus Continuation of Long‐term Therapy
Pontén, J., Biber, B., Bjurö, T., Henriksson, B. ‐., Hjalmarson, Å. C., & Lundberg, D. (1982) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1982.tb01890.x · Cited by 22
DiBianco, R., Katz, R. J., Chesler, E., Alpert, J. S., & Spann, J. F. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90806-9 · Cited by 21
Methodological Problems in Studies of Depressive Disorder: Utility of the Discontinuation Design
Quitkin, F. M., & Rabkin, J. G. (1981) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198109000-00003 · Cited by 20
β‐Receptor Blocker Withdrawal. A Preoperative Problem in General Surgery?
Pontén, J., Biber, B., Bjurö, T., Henriksson, B. ‐., & Hjalmarson, Å. C. (1982) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1982.tb01886.x · Cited by 20
Hallstrom, A. P., Verter, J. I., & Friedman, L. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90009-b · Cited by 17
Tapering of corticosteroid therapy following exacerbation of asthma
Campbell, D. S. (1988) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(88)80419-0 · Cited by 16
Effect of withdrawal of terazosin therapy in patients with hypertension
RUOFF, G. E. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90850-8 · Cited by 15
Absence of rebound from diltiazem therapy in Prinzmetal's variant angina
Schroeder, J. S., Walker, S. D., Skalland, M. L., & Hemberger, J. A. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80271-0 · Cited by 14
Dunk, A. A., Prabhu, U., Tobin, A., O’Morain, C. A., & Mowat, N. A. G. (1990) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1990.tb00460.x · Cited by 13
Need for Insulin Therapy in Type II Diabetes Mellitus: A Randomized Trial
Lm, F., Mulrow, C. D., Alexander, L. T., Harris, R. T., Heise, K. R., Brown, J. T., & Feussner, J. R. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.6.1085 · Cited by 13
Evans, J. R., Pacht, K. D., Huss, P., Unverferth, D. V., Bashore, T. M., & Leier, C. V. (1984) · PubMed · Cited by 12
Treatment of angina pectoris with lidoflazine.
Verhaeghe, L. K. (1969) · PubMed · Cited by 12
Are 'homeopathic' doses of oral corticosteroids effective in rheumatoid arthritis?
Buchanan, W. W., Stephen, L. J., & BUCHANAN, H. M. (1988) · PubMed · Cited by 12
Long-term Treatment of Irritable Bowel Syndrome: Results of a Randomized Controlled Trial
(1989) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068384 · Cited by 11
Giles, T. D., Sander, G. E., Roffidal, L., Thomas, M. G., Mersch, D. P., Moyer, R. R., Burris, J. F., Mroczek, W. J., & Brachfeld, J. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380080029010 · Cited by 9
Giles, T. D. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.8.1725 · Cited by 1
Research works printed but not linked: 1
- Snider, 1984, Sixmonth isoniazid-rifampin therapy for pulmonary tuberculosis, Am Rev Respir Dis, 129, 573
Cited by
Ratain, M. J., Eisen, T., Stadler, W. M., Flaherty, K. T., Kaye, S. B., Rosner, G. L., Gore, M., Desai, A. A., Patnaik, A., Xiong, H. Q., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6723 · Cited by 1,032
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Rini, B. I., & Small, E. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.186 · Cited by 408
Clinical Trial Designs for Cytostatic Agents: Are New Approaches Needed?
Korn, E. L., Arbuck, S. G., Pluda, J. M., Simon, R., Kaplan, R. S., & Christian, M. C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.265 · Cited by 331
MacLehose, Reeves, Harvey, Sheldon, Russell, & Black (2000) · Health Technology Assessment · doi:10.3310/hta4340 · Cited by 311
Metadata
- Authors
- Kopec, J. A., Abrahamowicz, M., & Esdaile, J. M.
- Affiliations
- Montreal General Hospital (CA)
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 1993-09
- Volume
- 46
- Issue
- 9
- Pages
- 959-971
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2073680312
- Cited by
- 134
- References
- 60
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 2 · 2022: 2 · 2020: 6 · 2019: 2 · 2018: 7 · 2017: 5 · 2016: 4 · 2015: 3 · 2014: 8 · 2013: 4 · 2012: 5
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Clinical Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI 07306, T32AI007306)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60AR036308, AR-36308, AR-07530, T32AR007530)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Management Science and Operations Research › Optimal Experimental Design Methods
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- relative efficiency, sample size, non-compliance, computer simulation, treatment effect estimation
- MeSH terms
- Computer Simulation, Humans, Models, Theoretical, Placebos, Research Design, Sampling Studies, Randomized Controlled Trials as Topic, Treatment Refusal, Efficiency, Organizational, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.